Liquent Debuts Electronic Regulatory Document Management System for Life Sciences at DIA Annual Meeting.

Business Editors/Health/Medical Writers

BIOWIRE2K

SAN ANTONIO--(BUSINESS WIRE)--June 16, 2003

New Solution in Line with Independent Market Research That Forecasts Increased Uptake in Electronic Regulatory Document Management Technologies

DRUG INFORMATION ASSOCIATION ANNUAL MEETING--Liquent, Inc., the global leader in regulatory publishing, intelligence, and intellectual property solutions, today unveiled Liquent InSight(TM) Foundation, Liquent's first product in its new InSight family of solutions that integrate document, publishing, and submission management technology. Designed from the ground up to leverage emerging standards like the Common Technical Document (CTD) and electronic Common Technical Document (eCTD), InSight Foundation provides a validation-ready solution for optimizing the management of a life sciences organization's submission-bound documents.

InSight Foundation extends a standard Document Management System (DMS) investment because it provides a configuration that is pre-tailored using industry best practices and is delivered as a validation-ready system. As a result, organizations can avoid costly investments in a customized DMS, which has traditionally steered smaller companies away from moving toward document management technology. Instead, users benefit from well-defined processes that guide organizations toward good content creation, review, security, and assembly without the endless consulting engagements that typify other solutions.

InSight Foundation's use of Documentum(R) as the DMS layer supports research conducted by industry analyst Frost & Sullivan on the Electronic Regulatory Document Management System (ERDMS) market, which concluded that the market is firmly dominated by Documentum with a 57% market share. InSight Foundation provides the best of both worlds by providing an ERDMS that combines best-practice business processes with the world's leading DMS.

"InSight Foundation is the convergence of enterprise-wide regulatory document control technology and automated regulatory submission assembly," explained Liquent President & CEO Rick Dool. "A major step in our overall technology vision, this new product demonstrates Liquent's commitment to helping life sciences organizations expand from straightforward submission publishing technology into regulatory document lifecycle management and publishing."

InSight, Liquent's synergistic product suite, integrates enterprise compliance processes including creation, publishing, consumption, and management of content. InSight offers tight integration between the DMS, publishing, and lifecycle management - all via an easy-to-use, web interface. Each InSight product is available as a stand-alone solution. However, used together as an integrated suite, they present significant benefits to the organization that would be difficult to achieve otherwise.

InSight Foundation will be generally available in the third quarter of 2003. Attendees of DIA are invited to see a demonstration and receive more information at booth #1553.

About Liquent, Inc.

Liquent, Inc. is the world's leading provider of content assembly, publishing, and regulatory and intellectual property information solutions for the life sciences industry. Based on a foundation of unparalleled rendering technology, Liquent's publishing solutions enable users to transform their proprietary content into open formats such as PDF and XML. Liquent's IDRAC database service provides the most comprehensive regulatory and intellectual property information on the drug and biologics regulatory environment in 33 of the largest markets in the world. In addition to technology and information, Liquent provides a full range of services to its clients including software implementation, business process analysis, staff augmentation, and complete regulatory publishing outsourcing for reports and submissions.

As a result, 47 of the top 50 global pharmaceutical companies rely on Liquent to stay current with regulatory requirements and to provide the technology and services to produce mission-critical documents including New Drug Applications, Marketing Authorization Applications, CTDs, reports, technical documentation, and more. Over the last decade, more than 5,000 regulatory submissions have been produced using Liquent's world-class products and expert services.

In addition to its headquarters in suburban Philadelphia, Liquent maintains offices in Research Triangle Park, NC. Liquent's European headquarters resides in Paris, France, with additional offices in the United Kingdom and Germany. Liquent is part of the Intellectual Property Group of Information Holdings, Inc. (NYSE: IHI). For more information, go to www.liquent.com.

About Information Holdings, Inc.

Information Holdings, Inc. is a leading provider of information products and services to scientific, technical, medical, intellectual property, and IT learning markets. Through its Intellectual Property Group, which includes MicroPatent(R), Master Data Center(TM), Liquent, and LPS Group, the company provides a broad array of databases, information products, and complementary services for intellectual property and regulatory professionals. The company is recognized as a leading provider of intellectual property information over the Internet.

The company's Transcender(R) unit is a leading online provider of IT certification test-preparation products. Its products include exam simulations for certifications from major hardware and software providers. Information Holdings, Inc. is listed on the New York Stock Exchange and trades under the symbol: IHI. For more information, go to www.informationholdings.com.